NorthRock Partners’s Clorox CLX Stock Holding History

NorthRock Partners’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,684	Closed	-$331K	–	681
2025 Q3	$331K	Buy	+2,684	New	+$333K	0.01%	664

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

NorthRock Partners's CLX Position: Q4 2025 in Review

NorthRock Partners sold out of Clorox (CLX) in Q4 2025, closing a stake of 2,684 shares — an estimated $331K sold.

NorthRock Partners first reported a position in CLX in Q3 2025 and held it in 1 quarter. The position peaked at $331K in Q3 2025. 1,053 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

NorthRock Partners reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
NorthRock Partners sold 2,684 Clorox shares in Q4 2025, an estimated $331K.
NorthRock Partners first reported a position in Clorox in Q3 2025 and held it in 1 quarter.
NorthRock Partners's Clorox position peaked at $331K in Q3 2025.
1,053 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on NorthRock Partners's 13F filing for Q4 2025, filed 17 Feb 2026.